Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy

Abstract

We wanted to investigate whether urine albumin/creatinine ratio (UACR) and left ventricular (LV) mass, both being associated with diabetes and increased blood pressure, predicted cardiovascular events in patients with hypertension independently. After 2 weeks of placebo treatment, clinical, laboratory and echocardiographic variables were assessed in 960 hypertensive patients from the LIFE Echo substudy with electrocardiographic LV hypertrophy. Morning urine albumin and creatinine were measured to calculate UACR. The patients were followed for 60±4 months and the composite end point (CEP) of cardiovascular (CV) death, nonfatal stroke or nonfatal myocardial infarction was recorded. The incidence of CEP increased with increasing LV mass (below the lower quartile of 194 g to above the upper quartile of 263 g) in patients with UACR below (6.7, 5.0, 9.1%) and above the median value of 1.406 mg/mmol (9.7, 17.0, 19.0%***). Also the incidence of CV death increased with LV mass in patients with UACR below (0, 1.4, 1.3%) and above 1.406 mg/mmol (2.2, 6.4, 8.0%**). The incidence of CEP was predicted by logUACR (hazard ratio (HR)=1.44** for every 10-fold increase in UACR) after adjustment for Framingham risk score (HR=1.05***), history of peripheral vascular disease (HR=2.3*) and cerebrovascular disease (HR=2.1*). LV mass did not enter the model. LogUACR predicted CV death (HR=2.4**) independently of LV mass (HR=1.01* per gram) after adjustment for Framingham risk score (HR=1.05*), history of diabetes mellitus (HR=2.4*) and cerebrovascular disease (HR=3.2*). *P<0.05, **P<0.01, ***P<0.001. In conclusion, UACR predicted CEP and CV death independently of LV mass. CV death was predicted by UACR and LV mass in an additive manner after adjustment for Framingham risk score and history of CV disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Liao Y et al. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997; 29: 648–650, (see comments).

    Article  Google Scholar 

  2. Borch-Johnsen K et al. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19: 1992–1997.

    Article  CAS  Google Scholar 

  3. Wachtell K et al. Are urinary albumin excretion and left ventricular hypertrophy both independent predictors of overall mortality in patients with electrocardiographic left ventricular hypertrophy? J Am Coll Cardiol 2002; 39: 237A.

    Article  Google Scholar 

  4. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B . Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria. Atherosclerosis 1995; 112: 245–252.

    Article  CAS  Google Scholar 

  5. Cirillo M et al. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: the Gubbio Population Study. Arch Intern Med 1998; 158: 1933–1939.

    Article  CAS  Google Scholar 

  6. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B . Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci (Colch) 1995; 88: 629–633.

    Article  CAS  Google Scholar 

  7. Jensen JS . Renal and systemic transvascular albumin leakage in severe atherosclerosis. Arterioscler Thromb Vasc Biol 1995; 15: 1324–1329.

    Article  CAS  Google Scholar 

  8. Olsen MH et al. Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. Am Heart J 2002; 144: 530–537.

    Article  Google Scholar 

  9. Dahlof B et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study (in process citation). Hypertension 1998; 32: 989–997.

    Article  CAS  Google Scholar 

  10. Wachtell K et al. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study. Hypertension 2000; 35(1 Part 1): 6–12.

    Article  CAS  Google Scholar 

  11. Devereux RB et al. Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study. Blood Press 2001; 10: 74–82.

    Article  CAS  Google Scholar 

  12. Sahn DJ, DeMaria A, Kisslo J, Weyman A . Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083.

    Article  CAS  Google Scholar 

  13. Schiller NB et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358–367.

    Article  CAS  Google Scholar 

  14. Palmieri V et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement (see comments). J Am Coll Cardiol 1999; 34: 1625–1632.

    Article  CAS  Google Scholar 

  15. Wachtell K et al. Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint. Am J Cardiol 2001; 87: 54–60.

    Article  CAS  Google Scholar 

  16. Dubin J, Wallerson DC, Cody RJ, Devereux RB . Comparative accuracy of Doppler echocardiographic methods for clinical stroke volume determination. Am Heart J 1990; 120: 116–123.

    Article  CAS  Google Scholar 

  17. de Simone G et al. Age-related changes in total arterial capacitance from birth to maturity in a normotensive population. Hypertension 1997; 29: 1213–1217.

    Article  CAS  Google Scholar 

  18. de Simone G et al. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23: 1444–1451.

    Article  CAS  Google Scholar 

  19. Devereux RB et al. Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. Hypertension 1998; 31: 929–936.

    Article  CAS  Google Scholar 

  20. Roman MJ et al. Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol 1995; 25: 83–90.

    Article  CAS  Google Scholar 

  21. Rowe DJ, Dawnay A, Watts GF . Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine. Ann Clin Biochem 1990; 27(Part 4): 297–312.

    Article  CAS  Google Scholar 

  22. Irgens-Moller L, Hemmingsen L, Holm J . Diagnostic value of microalbuminuria in pre-eclampsia. Clin Chim Acta 1986; 157: 295–298.

    Article  CAS  Google Scholar 

  23. Jensen JS, Borch-Johnsen K, Feldt-Rasmussen BF, Jensen G . Screening of microalbuminuria with the Micral-test. A semi-quantitative urinary dipstick. Ugeskr Laeger 1993; 155: 4155–4157.

    CAS  Google Scholar 

  24. Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE . Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ 1993; 306: 1722–1725.

    Article  CAS  Google Scholar 

  25. Feldt-Rasmussen B et al. Microalbuminuria: an important diagnostic tool. J Diabetes Complic 1994; 8: 137–145.

    Article  CAS  Google Scholar 

  26. Jensen JS et al. Reduced glomerular size- and charge-selectivity in clinically healthy individuals with microalbuminuria. Eur J Clin Invest 1995; 25: 608–614.

    Article  CAS  Google Scholar 

  27. Jensen JS et al. Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals. J Hum Hypertens 1997; 11: 727–732, (see comments).

    Article  CAS  Google Scholar 

  28. Olsen MH et al. Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. Am Heart J 2002; 144: 530–537.

    Article  Google Scholar 

  29. Roman MJ et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909–1918.

    Article  CAS  Google Scholar 

  30. Jones EC et al. Relation of hemodynamic volume load to arterial and cardiac size. J Am Coll Cardiol 1997; 29: 1303–1310.

    Article  CAS  Google Scholar 

  31. Vogt M, Motz W, Scheler S, Strauer BE . Disorders of coronary microcirculation and arrhythmias in systemic arterial hypertension. Am J Cardiol 1990; 65: 45G–50G.

    Article  CAS  Google Scholar 

  32. Koren MJ et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345–352.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Mary Paranicas, BA, Shonna Cohen, BA and Andreas Moan, MD, for their invaluable assistance with study coordination. Furthermore, we thank the LIFE echocardiography study investigators:

This work was supported in part by grants from Merck & Co., Inc., West Point, PA, USA.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M H Olsen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olsen, M., Wachtell, K., Bella, J. et al. Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy. J Hum Hypertens 18, 453–459 (2004). https://doi.org/10.1038/sj.jhh.1001711

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001711

Keywords

This article is cited by

Search

Quick links